Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Debonnel

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Neuroscience|April 1, 1996
Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioningG Debonnel, R Bergeron, F P Monnet, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1992
Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependencyF P Monnet, P Blier, G Debonnel, et al.
British Journal of Pharmacology|November 7, 1998
Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramineJ C Béïque, C de Montigny, P Blier, et al.
European Journal of Pharmacology|April 25, 1990
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptorsF P Monnet, G Debonnel, J L Junien, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Clinical and neuroendocrine studies with cholecystokinin peptidesN P Nair, D Bloom, S Lal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2001
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjectsJ E Turcotte, G Debonnel, C de Montigny, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Cholecystokinin-octapeptide in chronic schizophrenia: a double-blind placebo-controlled studyN P Nair, D M Bloom, G Debonnel, et al.
British Journal of Pharmacology|June 1, 1994
The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxinF P Monnet, G Debonnel, R Bergeron, et al.
The European Journal of Neuroscience|September 1, 1995
In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studiesP Bouchard, F Monnet, R Bergeron, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2005
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysisG Gobbi, F R Bambico, R Mangieri, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Neuroscience|April 1, 1996
Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioningG Debonnel, R Bergeron, F P Monnet, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1992
Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependencyF P Monnet, P Blier, G Debonnel, et al.
British Journal of Pharmacology|November 7, 1998
Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramineJ C Béïque, C de Montigny, P Blier, et al.
European Journal of Pharmacology|April 25, 1990
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptorsF P Monnet, G Debonnel, J L Junien, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Clinical and neuroendocrine studies with cholecystokinin peptidesN P Nair, D Bloom, S Lal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2001
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjectsJ E Turcotte, G Debonnel, C de Montigny, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Cholecystokinin-octapeptide in chronic schizophrenia: a double-blind placebo-controlled studyN P Nair, D M Bloom, G Debonnel, et al.
British Journal of Pharmacology|June 1, 1994
The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxinF P Monnet, G Debonnel, R Bergeron, et al.
The European Journal of Neuroscience|September 1, 1995
In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studiesP Bouchard, F Monnet, R Bergeron, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2005
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysisG Gobbi, F R Bambico, R Mangieri, et al.
Pageof 5